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X-ray phase-contrast imagingChanges in x-ray attenuating tissue caused by lung disorders like emphysema or ﬁbrosis are subtle and thus only
resolved by high-resolution computed tomography (CT). The structural reorganization, however, is of strong in-
ﬂuence for lung function. Dark-ﬁeld CT (DFCT), based on small-angle scattering of x-rays, reveals such structural
changes even at resolutions coarser than the pulmonary network and thus provides access to their anatomical
distribution. In this proof-of-concept study we present x-ray in vivo DFCTs of lungs of a healthy, an emphysema-
tous and a ﬁbroticmouse. The tomographies show excellent depiction of the distribution of structural – and thus
indirectly functional – changes in lung parenchyma, on single-modality slices in dark ﬁeld as well as on multi-
modal fusion images. Therefore, we anticipate numerous applications of DFCT in diagnostic lung imaging.We in-
troduce a scatter-basedHounsﬁeld Unit (sHU) scale to facilitate comparability of scans. In this newly deﬁned sHU
scale, the pathophysiological changes by emphysema and ﬁbrosis cause a shift towards lower numbers, com-
pared to healthy lung tissue.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Lung diseases pose one of the leading causes of death worldwide
(World Health Organization, 2011). A large fraction of those mortality
numbers is represented by chronic obstructive pulmonary disease
(Zvezdin et al., 2009), of which lung emphysema is a common compo-
nent. The disease is associated with inﬂammatory processes in lung tis-
sue caused most commonly by smoking. In consequence, the alveolar
walls necessary for gas exchange in the blood are destroyed, resulting
in enlarged distal air spaces and consequently deteriorated lung func-
tion and decreased quality of life (Ley-Zaporozhan et al., 2008). Pulmo-
nary ﬁbrosis can be idiopathic or caused by inhalation of pollutants,
infection, or adverse reactions to drugs (Bourke, 2006). In the course
of this interstitial lung disease normal parenchyma is gradually replaced
by connective tissue (scarring), resulting in a restricted lung and im-
paired gas exchange (King, 2005). The sensitivity and speciﬁcity ofyen), franz.pfeiffer@tum.de
. This is an open access article underconventional x-ray projection radiography in diagnosing those disor-
ders is low for mild to moderate stages (King, 2005; Washko, 2010),
and lung function testing is still gold standard, while direct assessment
of themicrostructural changes and disease progression is only available
via invasive biopsy. Attenuation-based high-resolution computed to-
mography (HRCT) serves for improved emphysema and ﬁbrosis imag-
ing, also providing information about the three-dimensional regional
distribution of the disease necessary for lung volume reduction surgery
(Washko et al., 2008; Criner and Mamary, 2010), but its use is limited
due to the required substantial radiation dose (Washko, 2010).
Contrary to conventional medical x-ray imaging, grating-based
phase-contrast and dark-ﬁeld imaging (PCI/DFI) generate contrast
from perturbations in the x-ray wave-front caused by refraction and
ultra-small angle scattering in tissue (Weitkamp et al., 2005). Its proven
feasibilitywith conventional polychromatic x-ray sources (Pfeiffer et al.,
2008; Pfeiffer et al., 2006) has recently triggered developments towards
preclinical and clinical translation, such as in vivo radiographic projec-
tion imaging (Bech et al., 2013) at a dedicated preclinical table-top scan-
ner (Tapfer et al., 2012). Earlier in vivo studies using different PCI/DFI
techniques were restricted to synchrotron radiation or very small ﬁeld
of view (Bravin et al., 2013). However, the beneﬁt of exploitingthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ways tissue could already be demonstrated in vivo at the synchrotron
(Lewis et al., 2005). In preceding studies, we introduced emphysema di-
agnosis on living mice based on x-ray scatter-based dark-ﬁeld projec-
tion imaging (Meinel et al., 2014; Hellbach et al., 2015).
In this work, we present the ﬁrst successful x-ray dark-ﬁeld (DF)
computed tomography (CT) scans of in vivo mice with a dedicated
micro-CT scanner (Tapfer et al., 2012). To exploit the DF signal's ability
to depict sub-resolution microstructures, thoracic tomographies were
acquired of a healthy control mouse, a mouse with pulmonary emphy-
sema and amouse with pulmonary ﬁbrosis. The scope of this study is to
highlight the feasibility and demonstrate the potential diagnostic bene-
ﬁt of the novel contrast modality in three-dimensional imaging. Com-
plementary to the quantitative Hounsﬁeld scale in attenuation-based
CT, we also introduce a scatter-based Hounsﬁeld scale for quantitative
DFCT of lung tissue.
2. Materials & Methods
2.1. Murine Model
Animals were housed in SPF rooms maintained at constant temper-
ature and humidity with a 12-h light cycle and were allowed food and
water ad libitum. All experiments were conducted under strict govern-
mental (GV-SOLAS) and international guidelines (FELASA) and were
approved under number 2532-77-12 by the local government for the
administrative region of Upper Bavaria. For this study 6 to 8 week old
pathogen-free female C57BL/6N (Charles River Laboratories, Sulzfeld,
Germany) mice were used. Pulmonary emphysema was introduced by
orotracheal application of an 80 μl solution of porcine pancreatic elas-
tase (80 U per kilogram bodyweight; Sigma-Aldrich, Munich,
Germany) in sterile phosphate-buffered saline (PBS). Pulmonary ﬁbro-
sis was provoked by orotracheal insertion of 2.5 U bleomycin per kg
bodyweight. The control animal was treated with 80 μl PBS only. Treat-
ments were performed under anesthesia by intraperitoneal injection
of medetomidine (500 μg/kg), midazolam (5 mg/kg) and fentanyl
(50 μg/kg). The anesthesia was then antagonized with a subcutaneous
injection of atipamezole (50 mg/ml), fulimazenil (0,1 mg/ml) and nal-
oxone (0,4 mg/ml). Control and emphysema mouse were scanned
21 days, ﬁbrosis mouse 14 days after application.
2.2. Grating-based Dark-ﬁeld and Phase-contrast Imaging
To measure perturbations of the x-ray wave front other than the
mere attenuation and to subsequently extract the dark-ﬁeld andFig. 1.Methodology of grating-based dark-ﬁeld and phase-contrast imaging. a: Sketch of a Talb
G0, phase grating G1, analyzer grating G2) the perturbations introduced by the sample to the x
detector. The original (reference) interference pattern created byG1 (dashed and solid black lin
blue line) due to attenuation, and in terms of smoothing of the extrema (reduced peaks and vall
in the samplewould result in a lateral shift of the blue relative to the black dashed line (not show
positions over one period of the interference pattern (‘phase stepping’), the pattern is sampled. b
a sample scan (superscript s) over one phase-stepping cycle. Bydetermining the change of the p
ﬁeld, and phase are extracted.phase-contrast signals, it is necessary to place optical elements, in our
case grating structures, into the x-ray beam path between source and
detector. The three gratings as displayed in the sketch in Fig. 1 a com-
prise the so-called Talbot–Lau interferometer: The source grating G0
counteracts the incoherence of the extended and polychromatic con-
ventional x-ray source by creating an array of smaller line sources that
exhibit sufﬁcient coherence. The phase gratingG1 acts as a beamsplitter
generating an interference pattern downstream. Relative to an empty
beam, placing an object into the setup inﬂuences the interference pat-
tern in three different ways: First, the overall intensity drops due to at-
tenuation. Second, the pattern is laterally shifted if the x-rays undergo a
resolvable refraction in thematerial, which is exploited as the (differen-
tial) phase contrast (for the sake of simplicity not shown in the sketch).
Third, scattering of the x-rays atmicrostructures that cannot be spatially
resolved by the imaging system causes the minima and maxima of the
interference pattern to be less pronounced, which is translated into
the dark-ﬁeld signal. As the pattern cannot be resolved directly by the
detector pixel size, the analyzer grating G2 is used to sample the inten-
sity variation: In a process called ‘phase stepping’ (Weitkamp et al.,
2005), several images are acquired at different lateral positions of the
three gratings relative to one another over one period of the pattern.
The intensity thereby recorded in one detector pixel over the grating
position can be described by a sinusoidal curve that changes its param-
eters offset, phase, and amplitude between an empty beam (reference)
and an object in the beam (see Fig. 1 b). Using sinusoidal ﬁts or Fourier
analysis, attenuation, differential phase and dark-ﬁeld signal are ex-
tracted respectively from the parameters of the two curves. Thus three
differentmodalities per projection angle are acquired. As in convention-
al CT, a three dimensional representation of the object can be calculated
also for dark-ﬁeld and phase-contrast imaging, using tomographic
image reconstruction algorithms.
2.3. Scanner Setup
The images were acquired using a dedicated small-animal x-ray
dark-ﬁeld and phase-contrast CT scanner developed in collaboration
with Bruker microCT (Tapfer et al., 2012). The scanner comprises a
setup consisting of detector (ﬂatpanel by Hamamatsu C9312SK-6),
source (tungsten-target x-ray tube RTW, MCBM 65B-50 W, approx.
50 μm focal spot) and Talbot–Lau interferometer on a rotating gantry
and facilities to monitor heart beat, breathing motion and tempera-
ture of the animal. The gratings of the interferometer are speciﬁed
by the following bar materials, heights, and periods, respectively:
G0 — gold, 35 μm, 10 μm; G1 — nickel, 4 μm, 3.2 μm; G2 — gold
45 μm, 4.8 μm.ot–Lau interferometry setup. By the use of three optical grating structures (source grating
-ray wave front are translated into intensity variations that can be measured by the x-ray
e) is changed by the presence of the object in terms of overall intensity (decreased offset of
eys of the blue line) due to scattering atmicrostructures. Resolvable refraction of the x-rays
n here for the sake of simplicity). By recording imageswith thedetector at different grating
:Measured intensity in one detector pixel for a reference (empty beam, superscript r) and
arameters offset a0, amplitude a1, and relative phaseϕ1, the three signals attenuation, dark-
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The mice were anesthetized as during emphysema or ﬁbrosis intro-
duction (seeMurine model) and placed on the sample bed in supine po-
sition. During acquisition they were breathing freely. Body temperature
and respiratory movementwere constantly monitored and the temper-
ature was kept stable via a built-in warm-air fan. All scans were
acquired at a source voltage of 35 kVp and a current of 524 μA. The de-
tector was operated in 2-by-2 binning mode, resulting in an effective
pixel size of 58 μm. According to the phase stepping method
(Weitkamp et al., 2005), for each angular gantry position a set of ﬁve
images with varying source-grating position was recorded applying an
exposure of 5 s. For each animal 139 angular views distributed over
360° were taken, resulting in a total exposure time of approximately
one hour and an accumulated dose of 200 mGy. For processing of the
raw phase stepping data, reference sets of phase steps were acquired
each time when the scan had progressed ten angular gantry positions.
For this, the mice were temporarily moved out of the beam path.
2.5. Raw Data Processing
Prior to extraction of attenuation, differential phase and dark-ﬁeld
signal, the raw stepping images were sharpened using Richardson–
Lucy deconvolutionwith themeasured point-spread function of the im-
aging system. Since the three modalities have differing noise behaviors,
the number of deconvolution iterationswas optimized for each imaging
channel individually, resulting in zero iterations for dark ﬁeld, one iter-
ation for attenuation and three iterations for differential phase images.
To extract attenuation, differential phase and dark-ﬁeld signal from
the phase stepping sets a pixel-wise sine ﬁt function was applied,
which additionally provides the variances on the signals that are re-
quired for the applied reconstruction technique. To counteract distor-
tions in the phase image caused by thermal and mechanical inﬂuences
on the grating structures, an adaptive phase recovery tool was applied
as described by Tapfer et al. (2012), but with the extension of using a
surface ﬁt, described by a polynomial of degree 2, to the sample-free
image margin instead of a ramp ﬁt over the complete image. Transmis-
sion and dark-ﬁeld images were corrected for variations in intensity by
a simple background normalization using areas with no sample cover-
age. Since all three imaging channels are extracted from the same raw
stepping set, the modalities are inherently perfectly co-registered.
2.6. Tomographic Reconstruction
As the mice cover approximately 675 pixels in width of the ﬁeld of
view, the scans are severely undersampled due to time constraints
posed by the anesthesia duration. To partly cope with the resulting arti-
facts in the tomographic reconstruction, a statistical iterative recon-
struction technique, described in detail by Hahn et al. (Hahn et al.,
2015), was applied with parameters optimized for each modality indi-
vidually but consistent between the datasets of the threemice. To coun-
teract overregularization and loss of detail in case of the attenuation CT,
the noise power spectrum of the three mice datasets were adjusted
by weighting iterative reconstruction and conventional ﬁltered back-
projection reconstruction (with Ram-Lak ﬁlter) with 0.75 and 0.25
respectively.
2.7. Post-processing
For representation and analysis purposes simple semi-automated
threshold-based segmentation was applied to differentiate mouse
torso, skeleton, lung, and surrounding air and animal bed by use of the
commercially available Software VGStudioMax 2.0 (Volume Graphics,
Heidelberg, Germany). In doing so, only minor manual corrections
were necessary. The segmentation of themouse torso from surrounding
structures was performed on the phase-contrast dataset, because itcontained the fewest artifacts inﬂuencing the outer shape of the
mouse. Segmentation of the bones and the lungs was performed
based on the attenuation data and the dark-ﬁeld data respectively,
exploiting their modality-inherent strongest signal differences to the
surrounding tissue. The perfect co-registration allows for simple trans-
fer of a segmentation in one modality to the volumes of the other mo-
dalities. The volume and surface renderings for the three-dimensional
representations (Fig. 3) and the supplemental movie (S2) of the
datasets were performed by Volume Graphics based on the aforemen-
tioned segmentations. The fusion images shown in Fig. 2 were created
from the isolated torsos in attenuation (gray) and dark ﬁeld (hot color
scheme) using the image fusion tool of OsiriX Imaging Software
v.3.7.1 64-bit (by Antoine Rosset) with the setting of 50% fusion and a
manual windowing for best visual appearance.
2.8. Histogram Analysis
To obtain a voxel set that objectively fully contains the lung for com-
parison of the dark-ﬁeld CT gray-value distributions between the mice,
the threshold-based segmentations (optimized for visual appearance)
were strongly dilated, so that a volume that comprises lung and partly
surrounding non-scattering soft tissue was achieved. Since apart from
lung tissue only the granular structure of bones can be a possible source
of scattering in this region, the rib cage was subtracted from this vol-
ume. The histograms shown in Fig. 4 represent the gray-value distribu-
tion of the remaining volumes. Since the processing, tomographic
reconstruction and post-processing was equivalent for each mouse
dataset, the distributions can be assumed quantitatively comparable
among each other. A peak-ﬁnder function was applied to a multi-
Gauss ﬁt of the histogram curves to determine the positions of the
zero-scatter peaks of all three mice and the lung peaks of control and
emphysematous mouse without inﬂuence of local extrema. The
rescaling of gray values (tiff range) to scatter Hounsﬁeld Units (HUs)
was done by setting the mean of the three zero-scatter peak positions
to 0 HUs and the location of lung peak of the control mouse to 1000 HUs.
2.9. Histology
After excision, the lungs were ﬁxated in paraformaldehyde for con-
servation during transport. They were subsequently washed to remove
the formalin solution and then decalciﬁed in a 10% EDTA solution for
5 days. The samples were dehydrated and embedded in parafﬁn. In
the coronal plane, multiple 10 μm thin slices were prepared at an inter-
val of 0.5 mm. After deparafﬁnization and hydration the slices were
stained using Mayer's hematoxylin and eosin (HE). Ultimately, they
were dehydrated and scanned.
3. Results
Fig. 2 provides an overview over the CT datasets of this study com-
prising three in vivo cases imaged in conventional attenuation and DF,
as well as correspondent histological slices to illustrate the nature of
the respective disease. Additionally, phase-contrast CT slices are pre-
sented in supplemental Fig. S1. Comparing the conventional CT scan of
the emphysematous mouse (Fig. 2 b, e) with the control (Fig. 2 a, d),
one observes only subtle differences towards darker gray values in pe-
ripheral lung tissue in the emphysematous case. The resolution of the
imaging system does not allow a direct depiction of the alveolar wall
structure. In the respective CT slices of the DF channel (Fig. 2 g, j for con-
trol, h, k for emphysema) the strong difference in signal allows for clear
discernibility between control and diseased case, as visible by the over-
all reduced brightness and decreased homogeneity in the diseased lung
compared to the healthy lung. The destruction of alveolar walls and
resulting enlargement of air spaces (as displayed in the corresponding
histological section in Fig. 2 n) causes signiﬁcantly reduced x-ray
Fig. 2. Exemplary attenuation and dark-ﬁeld CT slices and histological sections of lungs of three in vivomice. Pathophysiological changes are subtle in the attenuation-based, but clear in
scatter-based CT images as visible by the overall reduced brightness and decreased homogeneity of the signal in the diseased lungs compared to the healthy lung. Gray-value windows
chosen for best visual appearance, but consistent within the samemodality, respectively. Left-most column: Control mouse. Center column: Emphysematousmouse. Right-most column:
Fibrotic mouse. a–c: Coronal slices of attenuation CT. d–f: Axial slices of attenuation CT. g–i: Coronal slices of dark-ﬁeld CT. j–l: Axial slices of dark-ﬁeld CT.m–o: Histopathological slices
(HE-stained) of the lungs.
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decrease is weak.
When concentrating on the case of lung ﬁbrosis (Fig. 2 c, f for atten-
uation, i, l for DF) the replacement of functional alveolar network by
solid scar tissue is clearly apparent in bothmodalities, since the present-
ed case is at an advanced stage. TheDF image reveals areaswith remain-
ing functional alveolar structure. Histology illustrates the scarring in the
lung (Fig. 2 o), compared to healthy lung tissue (Fig. 2 m).
Fig. 3 shows a volumetric overview of the fusion of the attenuation
CT and DFCT for the two pathological cases emphysema (a–f) and ﬁbro-
sis (g–l). The fused representation, which is easily possible due to the
method-inherent perfect co-registration, provides a simultaneous im-
pression of anatomy depicted by the attenuation CT and functionality
indirectly displayed by DFCT, since alveolar structure can be related to
quality of gas exchange (Haraguchi et al., 1998). Similar to thefunction-anatomy combination in well-known multi-modal datasets
like PET–CT (PET: positron emission tomography), the conventional
attenuation CT images in gray shades were overlaid by DF data in
PET-typical hot color scheme. Note, however, that contrary to PET,
where hot areas indicate accumulation of tracer and therefore generally
diseased tissue, in the displayed fusion images the brighter color codes
the stronger scattering, i.e. the more intact or healthier lung tissue. The
combined representation allows for a comprehensive depiction of the
three-dimensional distribution of the diseases over the lung volume in
the anatomical frame. In the case of emphysema Fig. 3 shows that de-
struction of alveolar structures and size increase of air voids predomi-
nantly appears in peripheral regions of the lung as indicated by white
arrows. On the contrary, in Fig. 3 g–l arrows illustrate that the prolifer-
ation of the induced ﬁbrosis concentrates on the central, peribronchial
areas. Regarding the inherent complementarity of the two signals,
Fig. 3. Fusion images of attenuation and dark-ﬁeld CT of mouse with emphysematous lung (a–f) and mouse with ﬁbrotic lung (g–l) at different positions in the three-dimensional volume.
Emphysema case: Dark red areas indicating regions with strongly reduced scattering abilities (but little absorption) appear preferentially in the peripherals of the lung (white arrows). a–c:
Anterior to posterior coronal slices. d–f: Cranial to caudal axial slices. Fibrosis case: Red areas exhibit reduced scattering ability than bright yellow regions andmatch here with excessive tissue
marked by enhanced absorption in attenuationCT. Arrows indicate thepreferential spreadingof the scarring along the bronchi.g–i: Anterior to posterior coronal slices. j–l: Cranial to caudal axial
slices.
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tically to solid soft tissue, whereas they are distinguishable in attenua-
tion data.
The complementarity of theDF signalwith regard to the convention-
al attenuation-based signal allows for excellent differential diagnosis
between the two disorders emphysema and ﬁbrosis. While both typical
structural changes caused by the two disorders result in reduced scat-
tering of x-rays and thus decreased dark-ﬁeld signal, the combination
with the always inherently co-registered attenuation signal allows for
a distinction about the type of structural change, as the ﬁbrotic
parenchyma usually exhibits a stronger attenuation.
For a better three-dimensional impression Fig. 4 provides exemplary
views of volume renderings of the acquired datasets. Bones were seg-
mented from the attenuation signal, whereas lung tissue was extracted
from the DFCTs and represented by a semi-transparent hot colormap to
enhance inter- and intra-pulmonary structural variations. The 3D views
conﬁrm the earlier ﬁndings from the 2D slices: The control lung exhibits
a strong homogeneous scattering pattern all over its volume, whereas
the emphysema lung shows reduced scattering in the periphery and
the ﬁbrotic lung lacks scattering areas in the central, peribronchial
regions. In the supplemental material, we provide an animation of the
rendered multi-modal volumes (see Movie S2) to allow for a three-
dimensional assessment from different viewing angles.The strong difference in the identically windowed scatter-based
gray-values between the cases (Fig. 2 g–l) suggests that differentiation
betweendiseased and healthy tissuemerely based onDF signal strength
is possible. For a closer analysis, the histograms of the three lung-tissue
volumes (including a non-scattering soft-tissue margin) are shown
in Fig. 5. In attenuation-based CT – and recently in phase-contrast
CT (Donath et al., 2010) – , universal Hounsﬁeld Units (HU) were
established to facilitate comparability of data acquired at different scan-
ners. As an analogue approach, we introduce scatter-based Hounsﬁeld
Units (HUs). The established HU scales are deﬁned via their
tomographically reconstructed signals for water (0 HU) and for air
(−1000 HU), such that the HU number for tissue x is calculated via
the linear attenuation coefﬁcient μx in case of the attenuation HU scale:
HUx ¼ 1000  μx−μwaterμwater−μair
:
However, this deﬁnition cannot be transferred to DFCT, since both
water and air do not scatter and thus produce identical signals. There-
fore, we suggest the usage of a zero-scatter reference area to determine
0 HUs. This can be either water or air, or – in our case – non-scattering
solid soft-tissue, as it is included in the histogram-analyzed volume for
each of the three cases. The non-scattering parts form the three
Fig. 4. Volume renderings of a: emphysematous, b: control and c: ﬁbrotic case. The skeletal structure was segmented from attenuation CT, whereas the lung tissue was extracted from
dark-ﬁeld CT and represented by a semi-transparent hot color map. The renderings show the volumetric distribution of the overall reduced signal and its decreased homogeneity in
the diseased lungs compared to the healthy lung.
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1000HUswe propose the peak position of the strongest scatterer in our
measurements, the control lung, as reference point for 1000 HUs. Using
the linear diffusion coefﬁcient εx as ameasure for the scattering strength
of a material x as suggested by Bech et al. (Bech et al., 2010), we obtain
the deﬁnition
HUsx ¼ 1000  εx−ε0εControl−ε0
;
where ε0 is the linear diffusion coefﬁcient of a non-scattering area, so
ideally equal to 0, and εControl describes healthy lung tissue.
Hereby, destruction of alveolar structures results in a shift of the
main pulmonary peak towards the zero-scatter point, as it is the caseFig. 5. Histograms of the scatter-based gray values of the extended lung region of dark-
ﬁeld CT volumes of control (black), emphysematous (red) and ﬁbrotic (blue) mouse.
The gray values are scaled according to the novel scatter Hounsﬁeld Units (HUs) intro-
duced in the text. The pathophysiological changes of emphysematous and ﬁbrotic lung
cause a shift towards lower HUs. Peaks at 0 HUs correspond to non-scattering solid soft-
tissue areas surrounding the actual alveolar lung region.for the emphysematous lung with a peak position at approximately
373 HUs. Elimination of the air-ﬁlled voids is so advanced in some
areas of the ﬁbrotic lung, that the pulmonary peak merges into the
zero-scatter peak in this case. The increased peak height of the zero-
scatter peak reﬂects the substitution of those voids by non-scattering
solid soft tissue.
4. Discussion
The presented results reﬂect a proof-of-principle demonstration of
in vivoDFCT imaging and its possible beneﬁts in non-invasively evaluat-
ing pulmonary pathophysiology. For a detailed analysis of sensitivity
and speciﬁcity for diagnosing various lung diseases, studies with larger
sample sizes and several disease stages are required. To this end, our re-
sults show that this is in general feasible as dose-compatibility for lon-
gitudinal studies on small animals is given. Moreover, a whole atlas of
healthy lungmeasurements should be developed to serve for sound es-
tablishment of the suggested lung-speciﬁc HUs reference point, and is
beyond the scope of this proof-of-principle study. Ultimately, a stan-
dardized lung phantom needs to be developed based on this atlas to
guarantee reliable comparability of the HUs scale from different scan-
ners, because the DF signal strength depends on various parameters
such as feature (alveolar) size, x-ray energy or interferometer speciﬁca-
tions. We also want to point out that the applicability of a lung-based
HUs scale to other DFI applications, for example bones (Potdevin et al.,
2012), remains to be veriﬁed, since alternate applications may demand
setups of higher sensitivity.
To reach clinical application cases, certain technological limitations
of themethod need to be overcome, but are already subject to currently
on-going research and development efforts: For example, when trans-
lating the method to an increased torso diameter, an elevated x-ray en-
ergy is mandatory to reach the necessary penetration depth. The main
technological challenge is the manufacturing of high-aspect-ratio grat-
ing structures suitable for clinical energies, covering a large ﬁeld of
view (FOV).While sufﬁciently high aspect ratios have been demonstrat-
ed in experiment already (Willner et al., 2013; Ruiz-Yaniz et al., 2015;
Sarapata et al., 2014), the increase of the FOV by tiling gratings together
(Meiser et al., 2014) is under development. Concerning the dark-ﬁeld
signal strength, simulations and yet unpublished experiments have in-
dicated the feasibility of x-ray dark-ﬁeld projection imaging at clinically
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and scan time for clinical compatibility, acquisition schemes alternative
to the established ‘phase stepping’ (Weitkamp et al., 2005) have been
proposed (Zanette et al., 2011, 2012) and are being further investigated.
Despite the limited sample size of three cases in the present study,
the presented results prove great potential for future lung imaging
where volumetric information such as disease distribution is required.
One example is the use of x-ray scatter CT for the evaluation of potential
lung volume reduction surgery candidates (Washko, 2010) in case of
emphysema. In general, mild stages of emphysema are difﬁcult to diag-
nose by projection radiography only and often dose-intensive HRCT is
needed. Projection-based DFImayultimately serve as a screeningmeth-
od (Hellbach et al., 2015; Meinel et al., 2014; Schleede et al., 2012;
Yaroshenko et al., 2013). We imagine to complement this by limited-
angle or coarse-resolution DFCT to gain additional three-dimensional
information without the necessity of very high dose, exploiting that
DFI generates a signal from structure sizes below the resolution limit
of the imaging system (Chen et al., 2010; Yashiro et al., 2010; Lynch
et al., 2011). The presented CT results already serve as an example for
non-optimized resolution settings, because they are subject to
undersampling and breathing-motion artifacts due to non-gated acqui-
sition and long exposure times. This is possible as DFI proﬁts more from
noise reduction when changing to coarser resolution and suffers less
from the loss of detail than conventional attenuation (Velroyen et al.,
2013). Another conceivable application of thoracic DFCT is to map sus-
picious pulmonary parenchyma in case of suspected ﬁbrosis, without
the need to force the spatial resolution down to the level of the second-
ary pulmonary lobule. This may allow optimization of the location
choice for biopsy, which is still the gold standard for diagnosing idio-
pathic interstitial pneumonias and currently done with the help of
attenuation-based HRCT (Gross and Hunninghake, 2001).
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ebiom.2015.08.014.
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